Cytokinetics (CYTK) News Today $38.01 -0.57 (-1.48%) Closing price 07/15/2025 04:00 PM EasternExtended Trading$38.16 +0.15 (+0.39%) As of 07/15/2025 06:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CYTK Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Robert I. Blum Sells 5,000 Shares1 hour ago | insidertrades.comInsider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) CEO Sells 5,000 Shares of StockJuly 15 at 7:20 PM | marketbeat.comAllspring Global Investments Holdings LLC Sells 78,258 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)July 12, 2025 | marketbeat.comBanque Pictet & Cie SA Makes New $330,000 Investment in Cytokinetics, Incorporated (NASDAQ:CYTK)July 11, 2025 | marketbeat.comCytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2025July 10, 2025 | globenewswire.comCytokinetics (NASDAQ:CYTK) Shares Up 6.8% - Here's WhyJuly 9, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Stock Holdings Lifted by Brown Advisory Inc.July 9, 2025 | marketbeat.comPrincipal Financial Group Inc. Purchases 358,778 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)July 9, 2025 | marketbeat.comInsider Sell: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)July 8, 2025 | gurufocus.comInsider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) EVP Sells 2,000 Shares of StockJuly 8, 2025 | marketbeat.comPiper Sandler Maintains a Buy Rating on Cytokinetics (CYTK) With a $107 PTJuly 6, 2025 | msn.comCytokinetics, Incorporated (NASDAQ:CYTK) Given Consensus Recommendation of "Moderate Buy" by BrokeragesJune 26, 2025 | marketbeat.comCytokinetics Presents Positive Aficamten Data for Obstructive HCM at European Heart Failure CongressJune 25, 2025 | finance.yahoo.comFirst Week of February 2026 Options Trading For Cytokinetics (CYTK)June 21, 2025 | nasdaq.comInsider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)June 17, 2025 | gurufocus.comCytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)June 17, 2025 | globenewswire.comCytokinetics, Incorporated (NASDAQ:CYTK) CEO Sells $169,000.00 in StockJune 17, 2025 | insidertrades.comCytokinetics (NASDAQ:CYTK) Shares Down 3.1% - Time to Sell?June 16, 2025 | marketbeat.comGAMMA Investing LLC Boosts Stock Position in Cytokinetics, Incorporated (NASDAQ:CYTK)June 15, 2025 | marketbeat.comHarbor Capital Advisors Inc. Grows Position in Cytokinetics, Incorporated (NASDAQ:CYTK)June 12, 2025 | marketbeat.comCytokinetics, Incorporated (CYTK) Price Target Lowered To $53 from $71 at JPMorganJune 11, 2025 | insidermonkey.comCytokinetics Calls for DonationsJune 10, 2025 | baystreet.caCantor Fitzgerald Forecasts Cytokinetics FY2026 EarningsJune 10, 2025 | marketbeat.comCytokinetics Announces Call For Proposals For Annual Corporate Giving ProgramJune 10, 2025 | globenewswire.comCytokinetics (NASDAQ:CYTK) Price Target Cut to $53.00 by Analysts at JPMorgan Chase & Co.June 9, 2025 | marketbeat.comRhumbline Advisers Lowers Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)June 9, 2025 | marketbeat.com329,231 Shares in Cytokinetics, Incorporated (NASDAQ:CYTK) Purchased by E. Ohman J or Asset Management ABJune 6, 2025 | marketbeat.comRFG Advisory LLC Invests $1.29 Million in Cytokinetics, Incorporated (NASDAQ:CYTK)June 6, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Director Sells $116,715.60 in StockJune 5, 2025 | marketbeat.comInsider Selling: Cytokinetics, Incorporated (NASDAQ:CYTK) EVP Sells 8,659 Shares of StockJune 5, 2025 | marketbeat.comStock Traders Buy High Volume of Call Options on Cytokinetics (NASDAQ:CYTK)June 4, 2025 | marketbeat.comInsider Sell Alert: Fady Malik Sells 2,000 Shares of Cytokinetics Inc (CYTK)June 3, 2025 | gurufocus.comCytokinetics, Incorporated (NASDAQ:CYTK) CEO Sells $156,100.00 in StockJune 3, 2025 | marketbeat.comMirador Capital Partners LP Buys 33,489 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)June 2, 2025 | marketbeat.comCetera Investment Advisers Decreases Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)June 2, 2025 | marketbeat.comJefferies Financial Group Inc. Has $593,000 Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)May 31, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Lowers Stock Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK)May 31, 2025 | marketbeat.comMizuho Lowers Cytokinetics (NASDAQ:CYTK) Price Target to $84.00May 30, 2025 | marketbeat.comCytokinetics to Participate in the Jefferies Global Healthcare ConferenceMay 29, 2025 | globenewswire.comStifel Nicolaus Sticks to Its Buy Rating for Cytokinetics (CYTK)May 29, 2025 | theglobeandmail.comNuveen Asset Management LLC Trims Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)May 26, 2025 | marketbeat.comCytokinetics, Incorporated (NASDAQ:CYTK) Shares Purchased by Two Sigma Advisers LPMay 25, 2025 | marketbeat.comCytokinetics at RBC Conference: Strategic Insights on Drug DevelopmentMay 23, 2025 | uk.investing.comCytokinetics, Incorporated (NASDAQ:CYTK) Shares Sold by Zimmer Partners LPMay 23, 2025 | marketbeat.comProShare Advisors LLC Acquires 9,620 Shares of Cytokinetics, Incorporated (NASDAQ:CYTK)May 23, 2025 | marketbeat.com329,136 Shares in Cytokinetics, Incorporated (NASDAQ:CYTK) Bought by Nationale Nederlanden Powszechne Towarzystwo Emerytalne S.A.May 22, 2025 | marketbeat.comTeza Capital Management LLC Takes Position in Cytokinetics, Incorporated (NASDAQ:CYTK)May 22, 2025 | marketbeat.comBNP Paribas Financial Markets Trims Stake in Cytokinetics, Incorporated (NASDAQ:CYTK)May 22, 2025 | marketbeat.comVestal Point Capital LP Has $110.54 Million Holdings in Cytokinetics, Incorporated (NASDAQ:CYTK)May 21, 2025 | marketbeat.com47,383 Shares in Cytokinetics, Incorporated (NASDAQ:CYTK) Purchased by Tema Etfs LLCMay 20, 2025 | marketbeat.com Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Email Address CYTK Media Mentions By Week CYTK Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYTK News Sentiment▼0.850.97▲Average Medical News Sentiment CYTK News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYTK Articles This Week▼910▲CYTK Articles Average Week Get Cytokinetics News Delivered to You Automatically Sign up to receive the latest news and ratings for CYTK and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Intra-Cellular Therapies News Genmab A/S News Moderna News Dr. Reddy's Laboratories News Viatris News Qiagen News Ascendis Pharma A/S News BridgeBio Pharma News Verona Pharma PLC American Depositary Share News Blueprint Medicines News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYTK) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cytokinetics, Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Cytokinetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYTK Stock Alerts